Andrew Sonin, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 8200 E Belleview Ave, No 124, Greenwood Village, CO 80111 Phone: 303-761-9190 Fax: 720-874-4462 |
Dr. Camtu L Jones, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 5275 Dtc Pkwy, Greenwood Village, CO 80111 Phone: 702-243-6400 |
Michael Otte, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 8200 E Belleview Ave, No 124, Greenwood Village, CO 80111 Phone: 303-761-9190 Fax: 720-874-4462 |
Dr. David J Porter, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 8200 E Belleview Ave, 600, Greenwood Village, CO 80111 Phone: 303-761-9190 Fax: 720-874-4462 |
Dr. Terese I Kaske, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 8200 E Belleview Ave, No 102, Greenwood Village, CO 80111 Phone: 303-761-9190 Fax: 303-761-6322 |
Kevin Lampert, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 8200 E Belleview Ave, No 124, Greenwood Village, CO 80111 Phone: 303-761-9190 Fax: 720-874-4462 |
News Archive
The Zimbabwe HIV and AIDS Activist Union recently called on organizations involved in the fight against the disease to stop offering HIV tests if they cannot provide post-testing services, the Herald/AllAfrica.com reports.
Mortality rates in local jails declined over the period from 2000 through 2007, the Bureau of Justice Statistics in the Office of Justice Programs, U.S. Department of Justice, announced today. A total of 8,110 jail inmates died in custody of local jails over the study period, during which the mortality rate declined from 152 deaths per 100,000 jail inmates in 2000 to 141 per 100,000 in 2007.
The Food and Drug Administration has cleared the MAGNETOM Terra magnetic resonance imaging (MRI) scanner from Siemens Healthineers - the first-ever 7 Tesla (7T) MRI cleared for diagnostic imaging.
BioLineRx, a biopharmaceutical development company, announced today that it has received regulatory approval from the Finnish National Supervisory Authority for Welfare and Health (Valvira) to commence a Phase 1/2 safety trial for BL-7010, for the treatment of celiac disease.
Multiple laboratories have observed unusual neural activity resembling epilepsy in some lines of genetically modified mice widely used in neuroscience research.
› Verified 7 days ago